Article citationsMore>>
Kato-Stankiewicz, J., Hakimi, I., Zhi, G., Zhang, J., Serebriiskii, I., Guo, L., Edamatsu, H., Koide, H., Menon, S., Eckl, R., Sakamuri, S., Lu, Y., Chen, Q.Z., Agarwal, S., Baumbach, W.R., Golemis, E.A., Tamanoi, F. and Khazak, V. (2002) Inhibitors of Ras/Raf-1 Interaction Identified By Two-Hybrid Screening Revert Ras-Dependent Transformation Phenotypes in Human Cancer Cells. Proceedings of the National Academy of Sciences of the United States of America, 99, 14398-14403.
https://doi.org/10.1073/pnas.222222699
has been cited by the following article:
-
TITLE:
Two Small Molecules, ZCL278 and AZA197 Show Promise in Influencing Protein Interactions Involving the Ras-Related Protein Cell division cycle 42 [Cdc42] to Modulate Its Oncogenic Potential
AUTHORS:
Djamali Muhoza, Paul D. Adams
KEYWORDS:
Ras [Rat Sarcoma], Small Molecule Target, Cdc42, Protein-Protein Interactions
JOURNAL NAME:
Open Journal of Biophysics,
Vol.7 No.3,
May
15,
2017
ABSTRACT: Cdc42 is a member of the Rho subfamily of Ras-related proteins, which were among the first oncogenic proteins to be identified as playing a sig-nificant role in a variety of cellular events [Barbacaid, 1987, Ann. Rev. Biochem]. Equally important, Protein-Protein Interactions [PPIs] involving Cdc42 continue to highlight the role of Ras-related proteins’ relevance to cancer. As these proteins have been considered incapable of being “druggable”, due to a perceived lack of binding surface[s] that are amenable to small molecule targeting, there remains limited development of therapies to tackle diseased states caused by Cdc42-stimulated hyperactivity. Thusly, it has become important to characterize molecular details, including dynamics, of PPIs involving Cdc42 that may lend themselves as potential targets for therapeutic approaches. Recently, two small molecules, ZCL278 and AZA197, have shown promise in directly targeting Cdc42 to influence PPIs that are capable of causing Cdc42-stimulated abnormal signaling. In this editorial, we highlight recent studies that show case how these two small molecules may influence Cdc42-protein interactions.
Related Articles:
-
Dezhi Gao
-
Erdmann Görg
-
Moawwad E. A. El-Mikkawy
-
Giancarlo T. Tomezzoli
-
Fokam Tagne Achille Bernard, Marie Claire Komtangi, Julius Awah Ndukum, Fossi Josue, Djamen Tchantchou Chamberlin